Corinna Sorenson | Scholars@Duke

Corinna Sorenson
Assistant Professor in Population Health Sciences

Dr. Sorenson has extensive research and policy expertise in value assessment in health care, comparative effectiveness research, drug and device regulation and payment, and health policy evaluation. She is interested in the design, implementation, and assessment of innovative, evidence-based strategies to enhance value-based health care, particularly with regards to new and existing health care treatments and services. In this work, she also examines the economic, methodological, political, cultural, organizational, professional, and legal levers that support or hinder the adoption of such approaches.

Dr. Sorenson’s work also focuses on education and training development in health policy and management. She is currently Faculty Director of Graduate Education Initiatives and the Margolis Scholars in Health Policy and Management Program at the Duke-Margolis Center for Health Policy.

Outside of academe, Dr. Sorenson has served in senior health care consulting and policy positions in both the private and public sectors. She has also worked in an advisory capacity for governmental organizations in several countries on development of national and regional health technology assessment systems.

Current Research Interests

Health care spending, low-value care, value assessment, stakeholder engagement in health care and policy, value-based health care reforms, evidence-based policy, health care politics, health care governance

Current Appointments & Affiliations

Assistant Professor in Population Health Sciences, Population Health Sciences, Basic Science Departments 2017
Assistant Professor in the Sanford School of Public Policy, Sanford School of Public Policy, Duke University 2020
Member in the Duke Clinical Research Institute, Duke Clinical Research Institute, Institutes and Centers 2016
Associate of the Duke Initiative for Science & Society, Duke Science & Society, Initiatives 2018
Core Faculty Member, Duke-Margolis Center for Health Policy, Duke - Margolis Center For Health Policy, Initiatives 2019

Contact Information

corinna.sorenson@duke.edu

Background
Education, Training, & Certifications
- Ph.D., London School of Economics (United Kingdom) 2015
Duke Appointment History
- Adjunct Professor and Faculty Director of the Margolis Scholars Program, Sanford School of Public Policy, Duke University 2017 - 2019
- Adjunct Professor in the Sanford School of Public Policy, Sanford School of Public Policy, Duke University 2017
- Assistant Professor of Medicine, Medicine, General Internal Medicine, Medicine 2016 - 2017
- Adjunct Professor in the Fuqua School of Business, Fuqua School of Business, Duke University 2016
Leadership & Clinical Positions at Duke
- - Faculty Director, Graduate Education Initiatives and Margolis Scholars Program, Duke-Margolis Center for Health Policy
  - Faculty Steering Committee, Duke-Margolis Center for Health Policy
  - Faculty Education Advisory Committee, Duke-Margolis Center for Health Policy
  - Member, Department of Medicine Faculty Development Academy, Duke University, 9/2016-9/2018
Expertise
Subject Headings
Global Scholarship
- Research
  - Europe (Continent)
  - United Kingdom (Country)
Research
Selected Grants
- Accelerating Value-Based Care Impact at the State and National Level awarded by West Health Policy Center 2020 - 2023
- Accelerating Value-Based Care Impact at the State and National Level awarded by Gary and Mary West Health Institute 2020 - 2023
- Cardiovascular Risk Profile of LAL Deficiency Patients awarded by Alexion Pharmaceuticals, Inc. 2016 - 2020
- Exploring Value-Based Care from Various Perspectives awarded by PhRMA Foundation 2018 - 2019
- Exploring the Evidence on the Potential Impact of Reducing Areas of Low-Value Care awarded by National Pharmaceutical Council 2018 - 2019
- Challenges to Reducing Low-Value Care: Lessons Learned and Future Directions awarded by National Pharmaceutical Council 2017 - 2018
Publications & Artistic Works
Selected Publications
- Books
  - Sorenson, Corinna, Michael Drummond, and Panos Kanavos. Ensuring Value for Money in Health Care The Role of Health Technology Assessment in the European Union. WHO Regional Office Europe, 2008.
- Academic Articles
  - Mahendraratnam, Nirosha, Corinna Sorenson, Elizabeth Richardson, Gregory W. Daniel, Lisabeth Buelt, Kimberly Westrich, Jingyuan Qian, Hilary Campbell, Mark McClellan, and Robert W. Dubois. “Value-based arrangements may be more prevalent than assumed.” Am J Manag Care 25, no. 2 (February 2019): 70–76.
    Link to Item
  - Sorenson, Corinna, Gabriela Lavezzari, Gregory Daniel, Randy Burkholder, Marc Boutin, Edmund Pezalla, Gillian Sanders, and Mark McClellan. “Advancing Value Assessment in the United States: A Multistakeholder Perspective.” Value Health 20, no. 2 (February 2017): 299–307. https://doi.org/10.1016/j.jval.2016.11.030.
    Full Text Link to Item
  - Sorenson, Corinna, Michael Drummond, Aleksandra Torbica, Giuditta Callea, and Ceu Mateus. “The role of hospital payments in the adoption of new medical technologies: an international survey of current practice.” Health Economics, Policy and Law 10, no. 2 (April 2015): 133–59. https://doi.org/10.1017/s1744133114000358.
    Full Text
  - SORENSON, C. O. R. I. N. N. A., and M. I. C. H. A. E. L. DRUMMOND. “Improving Medical Device Regulation: The United States and Europe in Perspective.” Milbank Quarterly 92, no. 1 (March 2014): 114–50. https://doi.org/10.1111/1468-0009.12043.
    Full Text
  - Sorenson, C., M. K. Gusmano, and A. Oliver. “The Politics of Comparative Effectiveness Research: Lessons from Recent History.” Journal of Health Politics, Policy and Law 39, no. 1 (January 1, 2014): 139–70. https://doi.org/10.1215/03616878-2395199.
    Full Text
  - Sorenson, Corinna, Michael Drummond, and Grahame Wilkinson. “Use of innovation payments to encourage the adoption of new medical technologies in the English NHS.” Health Policy and Technology 2, no. 3 (September 2013): 168–73. https://doi.org/10.1016/j.hlpt.2013.05.001.
    Full Text
  - Sorenson, C., M. Drummond, and L. R. Burns. “Getting To Better Value From Medical Devices: Reimbursement And Pricing Policies In Europe And The United States.” Value in Health 16, no. 3 (May 2013): A249–A249. https://doi.org/10.1016/j.jval.2013.03.1268.
    Full Text
  - Sorenson, Corinna, Michael Drummond, and Lawton R. Burns. “Evolving Reimbursement And Pricing Policies For Devices In Europe And The United States Should Encourage Greater Value.” Health Affairs 32, no. 4 (April 2013): 788–96. https://doi.org/10.1377/hlthaff.2012.1210.
    Full Text
  - Sorenson, Corinna, Michael Drummond, and Kalipso Chalkidou. “Comparative Effectiveness Research: The Experience of the National Institute for Health and Clinical Excellence.” Journal of Clinical Oncology 30, no. 34 (December 1, 2012): 4267–74. https://doi.org/10.1200/jco.2012.42.1974.
    Full Text
  - Sorenson, Corinna. “Valuing end-of-life care in the United States: the case of new cancer drugs.” Health Economics, Policy and Law 7, no. 4 (October 2012): 411–30. https://doi.org/10.1017/s1744133112000217.
    Full Text
  - Sorenson, C., H. Naci, J. Cylus, and E. Mossialos. “Evidence of comparative efficacy should have a formal role in European drug approvals.” Bmj 343, no. sep06 1 (September 6, 2011): d4849–d4849. https://doi.org/10.1136/bmj.d4849.
    Full Text
  - Sorenson, C., R. Tarricone, M. Siebert, and M. Drummond. “Applying health economics for policy decision making: do devices differ from drugs?” Europace 13, no. suppl 2 (May 1, 2011): ii54–58. https://doi.org/10.1093/europace/eur089.
    Full Text
  - Sorenson, Corinna, and Panos Kanavos. “Medical technology procurement in Europe: A cross-country comparison of current practice and policy.” Health Policy 100, no. 1 (April 2011): 43–50. https://doi.org/10.1016/j.healthpol.2010.08.001.
    Full Text
  - Barnett, Tony, and Corinna Sorenson. “Infectious Disease Surveillance in the United States and the United Kingdom: From Public Goods to the Challenges of New Technologies.” Journal of Health Politics, Policy and Law 36, no. 1 (February 2011): 165–85. https://doi.org/10.1215/03616878-1191144.
    Full Text
  - Mladovsky, Philipa, and Corinna Sorenson. “Public Financing of IVF: A Review of Policy Rationales.” Health Care Analysis 18, no. 2 (June 2010): 113–28. https://doi.org/10.1007/s10728-009-0114-3.
    Full Text
  - Drummond, Michael, and Corinna Sorenson. “Can NICE Be Nicer? In a World of Budget Constraints There Are No Easy Solutions.” Value in Health 12, no. 5 (July 2009): 634–36. https://doi.org/10.1111/j.1524-4733.2009.00540.x.
    Full Text
  - Drummond, Michael, and Corinna Sorenson. “Nasty or Nice? A Perspective on the Use of Health Technology Assessment in the United Kingdom.” Value in Health 12 (June 2009): S8–13. https://doi.org/10.1111/j.1524-4733.2009.00552.x.
    Full Text
  - SORENSON, C. O. R. I. N. N. A. “Product development partnerships (PDPs) for neglected diseases: considerations on governance.” Health Economics, Policy and Law 4, no. 01 (January 2009): 1–1. https://doi.org/10.1017/s1744133108004702.
    Full Text
  - Oliver, Adam, and Corinna Sorenson. “Importance of preference reversals in the valuation of health and healthcare.” Expert Review of Pharmacoeconomics & Outcomes Research 8, no. 2 (April 2008): 95–99. https://doi.org/10.1586/14737167.8.2.95.
    Full Text
  - Martin, Greg, Corinna Sorenson, and Thomas Faunce. “Balancing intellectual monopoly privileges and the need for essential medicines.” Globalization and Health 3, no. 1 (2007): 4–4. https://doi.org/10.1186/1744-8603-3-4.
    Full Text
  - Sorenson, Carsten, and Carsten Drummond. “Socioeconomic value of orthopedic devices: evidence and methodological challenges.” Orthopedic Research and Reviews, n.d., 87–87. https://doi.org/10.2147/orr.s32453.
    Full Text
  - Sorenson, Corinna, Corinna Drummond, and Corinna Bhuiyan-Khan. “Medical technology as a key driver of rising health expenditure: disentangling the relationship.” Clinicoeconomics and Outcomes Research, n.d., 223–223. https://doi.org/10.2147/ceor.s39634.
    Full Text
  - Sorenson, Corinna, and Kalipso Chalkidou. “Reflections on the evolution of health technology assessment in Europe.” Health Economics, Policy and Law 7, no. 1 (n.d.): 25–45. https://doi.org/10.1017/s1744133111000296.
    Full Text
- Book Sections
  - “Use of Pharmacoeconomics in Drug Reimbursement in Australia, Canada and the UK. What Can We Learn From International Experience?” In Pharmacoeconomics From Theory to Practice. CRC Press, 2016.
  - “Measuring Value: Pharmacoeconomics Theory and Practice.” In The Oxford Handbook of the Economics of the Biopharmaceutical Industry. Oxford University Press, 2012.
  - “The Limitations and Challenges to the Economic Evaluation of Health Technologies.” In The Economics of New Health Technologies Incentives, Organization, and Financing. OUP Oxford, 2009.
- Reports
  - Jeswani, Nikita, Jay Jackson, Corinna Sorenson, Gillian Woollett, and Tanisha Carino. “Using Evidence to Support Value-Based Decision Making: Understanding Challenges to Manufacturer Communications. Washington, DC: Avalere Health.,” n.d.
  - Leinward, Brian, Kathy Hughes, Corinna Sorenson, and Michael Johnsrud. “A Case for Market-Based Costs in Determining Cost-Effectiveness: The Hepatitis C Example. Washington, DC: Avalere Health.,” n.d.
  - Sorenson, Corinna, Lawrence Burns, and Michael Drummond. “Medical Device Efficacy, Safety and Pricing Policy: A Comparative Analysis of the US and Europe. New York: The Commonwealth Fund.,” n.d.
  - Sorenson, Corinna, Michael Drummond, Finn Borlum Kristensen, and Reinhard Busse. “How Can the Impact of Health Technology Assessments be Enhanced? World Health Organization.,” n.d.
  - Sorenson, Corinna, Michael Drummond, Panos Kanavos, and Alistair McGuire. “National Institute for Health and Clinical Excellence (NICE). How Does it Work and What are The Implications for the U.S.? National Pharmaceutical Council, Arlington: VA.,” n.d.
  - Sorenson, Corinna. “The Use of Comparative Effectiveness Research for Evidence-Based Policy and Value for Money: A Six-Country Comparison of Drug Coverage and Pricing Decisions. New York: Commonwealth Fund.,” n.d.
- Conference Papers
  - Sorenson, C., L. Schauer, and M. McClellan. “Challenges to Reducing Low-Value Care: Lessons Learned and Future Directions.” In Value in Health, 21:S98–S98. Elsevier BV, 2018. https://doi.org/10.1016/j.jval.2018.04.661.
    Full Text
  - Sorenson, Corinna, Michael Drummond, and Beena Kahn. “Fact or fallacy: Does medical technology drive health care spending?,” n.d.
  - Sorenson, Corinna, Michael Drummond, and Graham Wilkerson. “Financing of medical devices,” n.d.
  - Sorenson, Corinna, and Michael Drummond. “Could NICE jump the pond? The international transferability of HTA,” n.d.
  - Sorenson, Corinna, and Michael Drummond. “Assessing the socio-economic value of medical devices: The case of cardiac care,” n.d.
  - Sorenson, Corinna, and Michael Drummond. “Decision making under uncertainty: Coverage with evidence development in the context of medical devices.,” n.d.
  - Sorenson, Corinna, and Michael Drummond. “A comparative analysis of international coverage with evidence development policies.,” n.d.
  - Sorenson, Corinna. “A Review of European HTA Systems: Methods, Conclusions, and Future Directions.,” n.d.
  - Sorenson, Corinna. “Networked governance: Transforming global health politics,” n.d.
  - Sorenson, Corinna. “Getting to better value from medical devices: Reimbursement and pricing policies in Europe and the US.,” n.d.
  - “The role of HTA in determining orphan and specialty drug coverage in Latin America.,” n.d.
  - “One size does not fit all: How traditional pricing and reimbursement policies affect orphan disease therapy access.,” n.d.
  - “Unplanned evidence: Implications of investigator-initiated trials (IIT),” n.d.
  - “Optimizing oncology reimbursement when limited by single-arm, single-agent trial design,” n.d.
  - “Biosimilar access: The future of value assessment.,” n.d.
  - “Use of CER in Europe.,” n.d.
  - “HTA influence mapping: Sourcing the primary opinion,” n.d.
  - “Stakeholder perceptions of economic evaluation,” n.d.
  - “Stakeholder views on health economic evaluation,” n.d.
  - “HTA development: What is the appropriate economic analysis?,” n.d.
  - “The impact of NICE guidance on the diffusion of medical devices.,” n.d.
  - “Use of innovation payments to encourage the adoption of new medical technologies in the English NHS.,” n.d.
  - “PROs and beyond: Are they fit for purpose to improve health care practice and policy?,” n.d.
Teaching & Mentoring
Recent Courses
Advising & Mentoring
- Experience with and availability to advise and mentor students interested in health policy. I also serve as the Faculty Director of the Margolis Scholars in Health Policy and Management Program. Interested students please visit: https://healthpolicy.duke.edu/scholars.
Scholarly, Clinical, & Service Activities
Outreach & Engaged Scholarship
- Bass Connections Faculty Team Leader. Transforming Alzheimer's Disease Care through Integrating Caregivers. 2018 - 2019 2018 - 2019

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Leadership & Clinical Positions at Duke

Subject Headings

Global Scholarship

Research

Selected Grants

Selected Publications

Books

Academic Articles

Book Sections

Reports

Conference Papers

Recent Courses

Advising & Mentoring

Outreach & Engaged Scholarship